This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $830 | To Be Confirmed. |
500mg | $1140 | To Be Confirmed. |
1g | $1710 | To Be Confirmed. |
Cat #: V4976 CAS #: 104632-27-1 (HCl) Purity ≥ 98%
Description: Dexpramipexole (also known as KNS-760704, R-(+)-Pramipexole and (R)-Pramipexole), an enantiomer of pramipexole, is a dopamine agonist of the non-ergoline class with the potential for the treatment of amyotrophic lateral sclerosis (ALS) (also known as Lou Gehrig’s disease).
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 284.25 |
---|---|
Molecular Formula | C10H19Cl2N3S |
CAS No. | 104632-27-1 (HCl) |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent |
Protocol | In Vitro | Dexpramipexole has been found to have neuroprotective effects and is being investigated for treatment of amyotrophic lateral sclerosis (ALS). Dexpramipexole reduces mitochondrial reactive oxygen species (ROS) production, inhibits the activation of apoptotic pathways, and increase cell survival in response to a variety of neurotoxins and β-amyloid neurotoxicity. Compared to the S-(-) isomer, Dexpramipexole has much lower dopamine agonist activity. |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 3.5180 mL | 17.5901 mL | 35.1803 mL | 70.3606 mL |
5mM | 0.7036 mL | 3.5180 mL | 7.0361 mL | 14.0721 mL |
10mM | 0.3518 mL | 1.7590 mL | 3.5180 mL | 7.0361 mL |
20mM | 0.1759 mL | 0.8795 mL | 1.7590 mL | 3.5180 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.